sb 203580 has been researched along with tetraethylammonium in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (tetraethylammonium) | Trials (tetraethylammonium) | Recent Studies (post-2010) (tetraethylammonium) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,877 | 10 | 298 |
| Protein | Taxonomy | sb 203580 (IC50) | tetraethylammonium (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.54 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 3.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coogan, AN; O'Connor, JJ | 1 |
| Sanders, PW; Ying, WZ | 1 |
2 other study(ies) available for sb 203580 and tetraethylammonium
| Article | Year |
|---|---|
Interleukin-1beta inhibits a tetraethylammonium-induced synaptic potentiation in the rat dentate gyrus in vitro.
Topics: Animals; Dentate Gyrus; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Humans; Imidazoles; In Vitro Techniques; Interleukin-1; Long-Term Potentiation; Male; N-Methylaspartate; Potassium Channel Blockers; Pyridines; Rats; Rats, Wistar; Tetraethylammonium; Time Factors | 1999 |
Dietary salt intake activates MAP kinases in the rat kidney.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Imidazoles; Kidney; Kidney Glomerulus; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Sodium Chloride, Dietary; Tetraethylammonium; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |